Synthesis and biological evaluation of N-substituted rhodanine derivatives bearing chalcone moiety as potent antimicrobial agents

XING Xiao-lan,LIU Ting-ting,SONG Ming-xia,LI Ya-ru,ZHANG Yu,LI Yan,LI Hua-shu,ZHENG Chang-ji,PIAO Hu-ri
DOI: https://doi.org/10.14142/j.cnki.cn21-1313/r.2013.01.005
2013-01-01
Abstract:Two new series of chalcone-based rhodanine derivatives bearing L-isoleucine or L-tryptophane moiety were designed.The target compounds were synthesized from different substituted acetophenones via condensation and Knoevenagel reaction and their in vitro antibacterial activities against seven Staphylococcus aureus strains(S.aureus RN 4220,S.aureus KCTC 503,S.aureus KCTC 209,MRSA CCARM 3167,MRSA CCARM 3506,QRSA CCARM 3505 and QRSA CCARM 3519) and Escherichia coli 1356 were tested using oxacillin and norfloxacin as positive controls.Twenty-eight new compounds,including(2R)-2-((Z)-5-(4-((E)-3-(substituted-phenyl)-3-oxoprop-1-en-1-yl)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-3-methylpentanoic acid(4a-4n) and(R)-2-((Z)-5-(4-((E)-3-(substituted-phenyl)-3-oxoprop-1-en-1-yl)benzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-3-(1H-indol-3-yl)propanoic acid(5a-5n) were prepared and their structures were confirmed by IR and 1H-NMR spectra.Most of the compounds displayed promising antimicrobial activities in vitro,Among which compounds 4n,5g and 5j exhibited the most potent with MIC values of 2 μg · mL-1 against the four multidrug-resistant clinical isolates.
What problem does this paper attempt to address?